However, recent expert consensus guidelines recommend genetic confirmation as essential, defining Alport syndrome more broadly to include all individuals harboring pathogenic variants in COL4A3, COL4A4, or COL4A5, regardless of their clinical presentation (6–8). This evidence concerns the gene COL4A4 and Alport syndrome.